Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marina Cuquerella-Gilabert

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Gaceta Sanitaria|September 15, 2022
[Addictions to information and communication technologies in Comunitat Valenciana (Spain), 2018-2020]Marina Cuquerella-Gilabert, Ana M García
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 28, 2025
Comparison of dissolution profiles: 90% confidence intervals of different f<sub>2</sub> estimators using bootstrap methodology versus the Euclidean Distance of the Non-standardized Expected (EDNE) valuesZhengguo Xu, Marina Cuquerella-Gilabert, Javier Zarzoso-Foj, et al.
Pharmaceutics|May 4, 2026
Model-Based Design of Sustained-Release Formulations of Anti-TNF-α Monoclonal Antibodies for Intravitreal AdministrationJavier Reig-López, Marina Cuquerella-Gilabert, Javier Zarzoso-Foj, et al.
Pharmaceutics|April 26, 2025
Physiologically-Based Biopharmaceutics Modeling for Ibuprofen: Identifying Key Formulation Parameter and Virtual Bioequivalence AssessmentJavier Zarzoso-Foj, Marina Cuquerella-Gilabert, Matilde Merino-Sanjuan, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 19, 2024
Bioequivalence risk assessment of oral formulations containing racemic ibuprofen through a chiral physiologically based pharmacokinetic model of ibuprofen enantiomersJavier Reig-López, Marina Cuquerella-Gilabert, Enrique Bandín-Vilar, et al.
Computer Methods and Programs in Biomedicine|November 25, 2023
Phys-DAT: A physiologically-based pharmacokinetic model for unraveling the dissolution, transit and absorption processes using PhysPK®Marina Cuquerella-Gilabert, Javier Reig-López, Jenifer Serna, et al.
Pharmaceutical Statistics|March 10, 2026
Leveraging Two-Stage δ Global Sensibility Analysis Method to Inform Parameter Estimation in PBPK ModelsMarina Cuquerella-Gilabert, Alessandro De Carlo, Sergio Sánchez Herrero, et al.
International Journal of Pharmaceutics|June 12, 2025
A physiologically based pharmacokinetic model to describe [<sup>89</sup>Zr]Zr-DFO-Adalimumab specific activity after intravitreal administration to rats with endotoxin-induced uveitisJavier Reig-López, Xurxo García-Otero, Marina Cuquerella-Gilabert, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Gaceta Sanitaria|September 15, 2022
[Addictions to information and communication technologies in Comunitat Valenciana (Spain), 2018-2020]Marina Cuquerella-Gilabert, Ana M García
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 28, 2025
Comparison of dissolution profiles: 90% confidence intervals of different f<sub>2</sub> estimators using bootstrap methodology versus the Euclidean Distance of the Non-standardized Expected (EDNE) valuesZhengguo Xu, Marina Cuquerella-Gilabert, Javier Zarzoso-Foj, et al.
Pharmaceutics|May 4, 2026
Model-Based Design of Sustained-Release Formulations of Anti-TNF-α Monoclonal Antibodies for Intravitreal AdministrationJavier Reig-López, Marina Cuquerella-Gilabert, Javier Zarzoso-Foj, et al.
Pharmaceutics|April 26, 2025
Physiologically-Based Biopharmaceutics Modeling for Ibuprofen: Identifying Key Formulation Parameter and Virtual Bioequivalence AssessmentJavier Zarzoso-Foj, Marina Cuquerella-Gilabert, Matilde Merino-Sanjuan, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 19, 2024
Bioequivalence risk assessment of oral formulations containing racemic ibuprofen through a chiral physiologically based pharmacokinetic model of ibuprofen enantiomersJavier Reig-López, Marina Cuquerella-Gilabert, Enrique Bandín-Vilar, et al.
Computer Methods and Programs in Biomedicine|November 25, 2023
Phys-DAT: A physiologically-based pharmacokinetic model for unraveling the dissolution, transit and absorption processes using PhysPK®Marina Cuquerella-Gilabert, Javier Reig-López, Jenifer Serna, et al.
Pharmaceutical Statistics|March 10, 2026
Leveraging Two-Stage δ Global Sensibility Analysis Method to Inform Parameter Estimation in PBPK ModelsMarina Cuquerella-Gilabert, Alessandro De Carlo, Sergio Sánchez Herrero, et al.
International Journal of Pharmaceutics|June 12, 2025
A physiologically based pharmacokinetic model to describe [<sup>89</sup>Zr]Zr-DFO-Adalimumab specific activity after intravitreal administration to rats with endotoxin-induced uveitisJavier Reig-López, Xurxo García-Otero, Marina Cuquerella-Gilabert, et al.
Pageof 1